反応式
Cl.C(N=C=NC[CH2:8][CH2:9][N:10]([CH3:12])C)C.O[N:14]1[C:18]2[CH:19]=[CH:20][CH:21]=[CH:22]C=2N=N1.[CH:23]([N:26](C(C)C)CC)(C)C.[CH:32]1([CH2:40][O:41][C:42]2[CH:50]=[CH:49][C:45]([C:46]([OH:48])=O)=[CH:44][CH:43]=2)[CH2:39][CH2:38][CH2:37][CH2:36][CH2:35][CH2:34][CH2:33]1.C1(CO)CCCCCCC1.CC[O:63][C:64](C)=[O:65]>CN(C=O)C>[CH:32]1([CH2:40][O:41][C:42]2[CH:43]=[CH:44][C:45]([C:46]([N:10]3[CH2:9][CH2:8][N:26]([C:64]([O:63][C:21]4[CH:22]=[N:14][CH:18]=[CH:19][CH:20]=4)=[O:65])[CH2:23][CH2:12]3)=[O:48])=[CH:49][CH:50]=2)[CH2:33][CH2:34][CH2:35][CH2:36][CH2:37][CH2:38][CH2:39]1参加物
反応物 6
生成物 1
試薬・触媒・溶媒 1
実験手順
1-Ethyl-3-(dimethylaminopropyl)carbodiimide hydrochloride (150 mg), 1-hydroxybenzotriazole (110 mg) and diisopropylethylamine (0.23 ml) were added to a DMF (5 ml) solution containing the resulting compound (190 mg) and 4-(cyclooctylmethoxy)benzoic acid (176 mg) prepared from cyclooctylmethanol with reference to Reference Example 70, followed by stirring overnight at room temperature. The reaction solution was diluted with EtOAc, the organic layer was washed with aqueous saturated sodium hydrogencarbonate solution, and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure, and the residue was recrystallized from EtOAc/hexane to obtain 3-pyridyl 4-[4-(cyclooctylmethoxy)benzoyl]-1-piperazinecarboxylate (240 mg).
後処理
- washthe organic layer was washed with aqueous saturated sodium hydrogencarbonate solution
- dry with materialdried over anhydrous sodium sulfate
- customThe solvent was evaporated under reduced pressure
- customthe residue was recrystallized from EtOAc/hexane
出典と根拠
- ORDレコード
- ord-08f67960fcfb40128f1ed3f5e434b715
- 出典データセット
- uspto-grants-2011_03
- 特許番号
- US07915261B2
関連ノート
読み込み中…